rociletinib
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for rociletinib, covering 2016-12-15 to 2020-08-12. Get the full timeline:
Most recent: Clinical Trial Update: Multicenter Study of Rociletinib Administered to Patients With Previously Treated Mutant EGFR Non-small Cell Lung Cancer [Phase 2]